|
1
|
Ferlay J, Colombet M, Soerjomataram I,
Parkin DM, Piñeros M, Znaor A and Bray F: Cancer statistics for the
year 2020: An overview. Int J Cancer: April 5, 2021 (Epub ahead of
print).
|
|
2
|
Arnold M, Sierra MS, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global patterns and trends in
colorectal cancer incidence and mortality. Gut. 66:683–691.
2017.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Marx O, Mankarious M and Yochum G:
Molecular genetics of early-onset colorectal cancer. World J Biol
Chem. 14:13–27. 2023.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Allam AR, Elsayed MA, Daghash IT,
Abdelaziz AM, Mostafa OM, Sabra HK, Eldaboush AM, Ahmed NMB, Elweza
RT, Adwy ES, et al: Colonoscopy screening for colorectal cancer in
Egypt: A nationwide cross-sectional study. BMC Cancer.
24(131)2024.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Rashad N, Salem SE, Meheissen MAM, Refaat
G, Sami HM, Temerik A, Kordy N, Daniel MA, El-Kaffas M, Esam M, et
al: Early-onset colorectal cancer in Egypt: Pathological
characters, patterns of care, and survival compared to average-age
onset colorectal cancer: A retrospective multicenter study. JCO
Glob Oncol. 10(e2300372)2024.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Ibrahim AH and Shash E: General oncology
care in Egypt. In: Al-Shamsi HO, Abu-Gheida IH, Iqbal F and
Al-Awadhi A (eds). Cancer in the Arab World. Singapore: Springer
Singapore, pp41-61, 2022.
|
|
7
|
Aran V, Victorino AP, Thuler LC and
Ferreira CG: Colorectal cancer: Epidemiology, disease mechanisms
and interventions to reduce onset and mortality. Clin Colorectal
Cancer. 15:195–203. 2016.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Farouk S, El-Shenawy R, Khairy AM and
Bader El-Din NG: Overexpression of miRNA 26a and 26b with MMP-9 are
valuable diagnostic biomarkers for colorectal cancer patients.
Biomark Med. 17:159–169. 2023.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Ahmadi A, Bayatiani MR, Seif F, Ansari J,
Rashidi P, Moghadasi M and Etemadi M: Evaluation of zadiotherapy on
miR-374 gene expression in colorectal cancer patient blood samples.
Rep Biochem Mol Biol. 10:614–621. 2022.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Ahmad R, Singh JK, Wunnava A, Al-Obeed O,
Abdulla M and Srivastava SK: Emerging trends in colorectal cancer:
Dysregulated signaling pathways (review). Int J Mol Med.
47(14)2021.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Pasquier J, Abu-Kaoud N, Al Thani H and
Rafii A: Epithelial to mesenchymal transition in a clinical
perspective. J Oncol. 2015(792182)2015.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Lei Y, Chen L, Zhang G, Shan A, Ye C,
Liang B, Sun J, Liao X, Zhu C, Chen Y, et al: MicroRNAs target the
Wnt/β-catenin signaling pathway to regulate epithelial-mesenchymal
transition in cancer (review). Oncol Rep. 44:1299–1313.
2020.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Smolarz B, Durczyński A, Romanowicz H,
Szyłło K and Hogendorf P: miRNAs in cancer (review of literature).
Int J Mol Sci. 23(2805)2022.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Di Z, Di M, Fu W, Tang Q, Liu Y, Lei P, Gu
X, Liu T and Sun M: Integrated analysis identifies a nine-microRNA
signature biomarker for diagnosis and prognosis in colorectal
cancer. Front Genet. 11(192)2020.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Kim Y, Sim J, Kim H, Bang SS, Jee S, Park
S and Jang K: MicroRNA-374a expression as a prognostic biomarker in
lung adenocarcinoma. J Pathol Transl Med. 53:354–360.
2019.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Choi JA, Kim H, Kwon H, Lee EH, Cho H,
Chung JY and Kim JH: Ascitic autotaxin as a potential prognostic,
diagnostic, and therapeutic target for epithelial ovarian cancer.
Br J Cancer. 129:1184–1194. 2023.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Ji R, Zhang X, Gu H, Ma J, Wen X, Zhou J,
Qian H, Xu W, Qian J and Lin J: miR-374a-5p: A new target for
diagnosis and drug resistance therapy in gastric cancer. Mol Ther
Nucleic Acids. 18:320–331. 2019.PubMed/NCBI View Article : Google Scholar
|
|
18
|
O'Brien SJ, Netz U, Hallion J, Bishop C,
Stephen V, Burton J, Paas M, Feagins K, Pan J, Rai SN and Galandiuk
S: Circulating plasma microRNAs in colorectal neoplasia: A pilot
study in assessing response to therapy. Transl Oncol.
14(100962)2021.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Bayatiani MR, Ahmadi A, Aghabozorgi R and
Seif F: Concomitant Up-regulation of Hsa-Mir-374 and
down-regulation of its targets, GSK-3β and APC, in tissue samples
of colorectal cancer. Rep Biochem Mol Biol. 9:408–416.
2021.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Chen B, Xia Z, Deng YN, Yang Y, Zhang P,
Zhu H, Xu N and Liang S: Emerging microRNA biomarkers for
colorectal cancer diagnosis and prognosis. Open Biol.
9(180212)2019.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Cai J, Guan H, Fang L, Yang Y, Zhu X, Yuan
J, Wu J and Li M: MicroRNA-374a activates Wnt/β-catenin signaling
to promote breast cancer metastasis. J Clin Invest. 123:566–579.
2013.PubMed/NCBI View
Article : Google Scholar
|
|
22
|
Vallée A, Lecarpentier Y, Guillevin R and
Vallée JN: Interactions between TGF-β1, canonical WNT/β-catenin
pathway and PPAR γ in radiation-induced fibrosis. Oncotarget.
8:90579–90604. 2017.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Xu S, Zhou Y, Biekemitoufu H, Wang H, Li
C, Zhang W and Ma Y: Expression of Twist, Slug and Snail in
esophageal squamous cell carcinoma and their prognostic
significance. Oncol Lett. 21(184)2021.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Xu L, Li M, Wang M, Yan D, Feng G and An
G: The expression of microRNA-375 in plasma and tissue is matched
in human colorectal cancer. BMC Cancer. 14(714)2014.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Dhasarathy A, Phadke D, Mav D, Shah RR and
Wade PA: The transcription factors Snail and Slug activate the
transforming growth factor-beta signaling pathway in breast cancer.
PLoS One. 6(e26514)2011.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Calon A, Espinet E, Palomo-Ponce S,
Tauriello DVF, Iglesias M, Céspedes MV, Sevillano M, Nadal C, Jung
P, Zhang XHF, et al: Dependency of colorectal cancer on a
TGF-β-driven program in stromal cells for metastasis initiation.
Cancer Cell. 22:571–584. 2012.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Baba AB, Rah B, Bhat GR, Mushtaq I,
Parveen S, Hassan R, Hameed Zargar M and Afroze D: Transforming
growth factor-beta (TGF-β) signaling in cancer-A betrayal within.
Front Pharmacol. 13(791272)2022.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Wodziński D, Wosiak A, Pietrzak J,
Świechowski R, Kordek R and Balcerczak E: Assessment of the TGFB1
gene expression and methylation status of the promoter region in
patients with colorectal cancer. Sci Rep. 12(11488)2022.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Bader El Din NG, Ibrahim MK, El-Shenawy R,
Salum GM, Farouk S, Zayed N, Khairy A and El Awady M: MicroRNAs
expression profiling in Egyptian colorectal cancer patients. IUBMB
Life. 72:275–284. 2020.PubMed/NCBI View
Article : Google Scholar
|
|
31
|
Fu J, Imani S, Wu MY and Wu RC:
MicroRNA-34 family in cancers: Role, mechanism, and therapeutic
potential. Cancers (Basel). 15(4723)2023.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Bakrim S, El Hachlafi N, Khalid A, Abdalla
AN, El Omari N, Aboulaghras S, Sakran AM, Goh KW, Ming LC, Razi P
and Bouyahya A: Recent advances and molecular mechanisms of TGF-β
signaling in colorectal cancer, with focus on bioactive compounds
targeting. Biomed Pharmacother. 177(116886)2024.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Farouk S, Khairy A, Salem AM, Soliman AF
and Bader El Din NG: Differential expression of miR-21, miR-23a,
and miR-27a, and their diagnostic significance in Egyptian
colorectal cancer patients. Genet Test Mol Biomarkers. 24:825–834.
2020.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Bader El Din NG, Farouk S, Abdel-Salam LO
and Khairy A: The potential value of miRNA-223 as a diagnostic
biomarker for Egyptian colorectal patients. Eur J Gastroenterol
Hepatol. 33:25–31. 2021.PubMed/NCBI View Article : Google Scholar
|
|
35
|
He W, Feng L, Xia D and Han N: MiR-374a
promotes the proliferation of human osteosarcoma by downregulating
FOXO1 expression. Int J Clin Exp Med. 8:3482–3489. 2015.PubMed/NCBI
|
|
36
|
Zhang H, Wang Z, Ma R, Wu J and Feng J:
MicroRNAs as biomarkers for the progression and prognosis of colon
carcinoma. Int J Mol Med. 42:2080–2088. 2018.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Son D, Kim Y, Lim S, Kang HG, Kim DH, Park
JW, Cheong W, Kong HK, Han W, Park WY, et al: miR-374a-5p promotes
tumor progression by targeting ARRB1 in triple negative breast
cancer. Cancer Lett. 454:224–233. 2019.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Chen Y, Jiang J, Zhao M, Luo X, Liang Z,
Zhen Y, Fu Q, Deng X, Lin X, Li L, et al: microRNA-374a suppresses
colon cancer progression by directly reducing CCND1 to inactivate
the PI3K/AKT pathway. Oncotarget. 7:41306–41319. 2016.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Zhen Y, Fang W, Zhao M, Luo R, Liu Y, Fu
Q, Chen Y, Cheng C, Zhang Y and Liu Z:
miR-374a-CCND1-pPI3K/AKT-c-JUN feedback loop modulated by PDCD4
suppresses cell growth, metastasis, and sensitizes nasopharyngeal
carcinoma to cisplat. Oncogene. 36:275–285. 2017.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Barnard JA, Warwick GJ and Gold LI:
Localization of transforming growth factor beta isoforms in the
normal murine small intestine and colon. Gastroenterology.
105:67–73. 1993.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Li X, Wu Y and Tian T: TGF-β signaling in
metastatic colorectal cancer (mCRC): From underlying mechanism to
potential applications in clinical development. Int J Mol Sci.
23(14436)2022.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Itatani Y, Kawada K and Sakai Y:
Transforming growth factor-β signaling pathway in colorectal cancer
and its tumor microenvironment. Int J Mol Sci.
20(5822)2019.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Hao Y, Baker D and Ten Dijke P:
TGF-β-mediated epithelial-mesenchymal transition and cancer
metastasis. Int J Mol Sci. 20(2767)2019.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Chen P, Guo X, Zhang L, Zhang W, Zhou Q,
Tian Z, Zheng Y, Liao Q, Wang H, Li G, et al: MiR-200c is a
cMyc-activated miRNA that promotes nasopharyngeal carcinoma by
downregulating PTEN. Oncotarget. 8:5206–5218. 2017.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Liu Q, Chen G, Moore J, Guix I,
Placantonakis D and Barcellos-Hoff MH: Exploiting canonical TGFβ
signaling in cancer treatment. Mol Cancer Ther. 21:16–24.
2022.PubMed/NCBI View Article : Google Scholar
|
